Accelerate to discover
Related topics
Low-dose maging in a new preclinical total-body PET/CT scanner
Aug 28, 2019
Ionizing radiation constitutes a health risk to imaging scientists and study animals. Both PET and CT produce ionizing...
Bruker Plans to Develop World’s Highest Field Preclinical MRI System for Oncology and Neuroscience
Aug 23, 2019
Bruker, a leading manufacturer of magnetic resonance imaging equipment, is working on the development of a powerful new...
Assessment of pro-arrhythmic effects using xCELLigence Cardio system and Pluricyte Cardiomyocytes
Aug 21, 2019
The combination of Pluricyte Cardiomyocytes and the xCELLigence RTCA Cardio ECR system enables detailed ...
Bruker announces acquisition of preclinical and molecular imaging research software provider PMOD
Aug 19, 2019
The PMOD software is widely used for the analysis of positron emission tomography (PET) studies in neurology,...
Fluxion Biosciences launches custom liquid biopsy NGS panel development
Aug 14, 2019
Fluxion a leading developer of precision solutions for life science research and diagnostics, announced that can...
Superior flow cytometry data with NEW Curiox Laminar Wash systems - centrifuge - less washing
Aug 12, 2019
The Laminar Wash technology provides an advantage to scientists in processing suspension cells for flow cytometry....
New Cytek Full Spectrum Viewer tool, a powerful guide for your fluorochrome choices
Aug 2, 2019
Want to see which fluorochromes have unique signatures and which are identical? Then the Cytek Full Spectrum Viewer...
Feel empowered with new IncuCyte SX1 live cell analysis system
Jul 17, 2019
Today’s new normal requires doing more with less. You need physiologically relevant, information-rich cell analysis...
Sep 29, 2015
The xCELLigence RTCA CardioECR System allows for comprehensive evaluation of processes involved in cardiomyocyte excitation-contraction coupling. The included software package is specifically designed to identify and measure adverse compound action on integrated ion channel activity, contractility and longer term viability and thus provides a highly predictive assay system for cardiac risk assessment.
The principle of detection for the xCELLigence RTCA CardioECR System is based on impedance and field potential measurements. The interdigitated gold impedance electrodes are interspersed with two field potential electrodes. These electrodes are specially designed for simultaneous measurement of field potential and contractility within each well of the microtiter plate.
Related technologies: Real-time, label free cell analysis
Get more info
Brand profile
ACEA manufactures xCELLigence impedance-based, label-free, real time cell analysis system and NovoCyte flow cytometers.
More info at:
www.aceabio.com
BioFocus newsletter
Register to receive Brand new technology development, Important product updates, Interesting scientific events and more!
BioTech a.s. © 2014
Designed & developed by imagineit
Technologies
